Cargando…
Drug Development in Pemphigoid Diseases
Pemphigoid diseases are organ-specific autoimmune diseases of the skin and/or mucous membranes. They are caused by autoantibodies targeting adhesion molecules located at the dermal–epidermal junction. While the diagnostics of pemphigoid diseases and insights into their pathogenesis have improved sig...
Autores principales: | BIEBER, Katja, LUDWIG, Ralf J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128935/ https://www.ncbi.nlm.nih.gov/pubmed/32039458 http://dx.doi.org/10.2340/00015555-3400 |
Ejemplares similares
-
Current Clinical Trials in Pemphigus and Pemphigoid
por: Izumi, Kentaro, et al.
Publicado: (2019) -
Milestones in Personalized Medicine in Pemphigus and Pemphigoid
por: Bieber, Katja, et al.
Publicado: (2021) -
Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases
por: Bieber, Katja, et al.
Publicado: (2017) -
The relevance of complement in pemphigoid diseases: A critical appraisal
por: Papara, Cristian, et al.
Publicado: (2022) -
Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
por: Tukaj, Stefan, et al.
Publicado: (2022)